Raymond James Starts Mirum Pharamceuticals (MIRM) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Citi Starts Mirum Pharamceuticals (MIRM) at Buy
August 12, 2019 6:16 AM EDTCiti analyst Joel Beatty initiates coverage on Mirum Pharamceuticals (NASDAQ: MIRM) with a Buy rating and a price target of $21.00.
For an analyst ratings summary and ratings history on Mirum Pharamceuticals click here. For more ratings news on Mirum Pharamceuticals click here.
Shares of Mirum Pharamceuticals closed at $14.77 yesterday.
... MoreEvercore ISI Starts Mirum Pharamceuticals (MIRM) at Outperform
August 12, 2019 6:14 AM EDTEvercore ISI analyst Josh Schimmer initiates coverage on Mirum Pharamceuticals (NASDAQ: MIRM) with a Outperform rating.
For an analyst ratings summary and ratings history on Mirum Pharamceuticals click here. For more ratings news on Mirum Pharamceuticals click here.
Shares of Mirum Pharamceuticals closed at $14.77 yesterday.
... More